Core Insights - Celestica Inc. (NYSE:CLS) is highlighted as a significant player in the AI ecosystem, particularly due to its partnership with Broadcom, which positions it favorably in the market [2] - Jim Cramer emphasizes that the perception of AI demand as "zero sum" is misguided, suggesting that there is ample opportunity for multiple companies to thrive in this space [2] - Celestica's stock has seen a remarkable increase of approximately 270-280%, indicating strong market performance and investor interest [2] Company Overview - Celestica Inc. provides contract manufacturing, supply chain, and various services to businesses, making it a key player in the technology supply chain [2] - The company is recognized as a preferred partner for Broadcom, which enhances its credibility and potential for growth within the AI sector [2] Market Perspective - The discussion around Celestica reflects a broader trend in the market where multiple players can coexist and succeed, countering the notion that advancements by one company necessarily detract from others [2] - There is a belief that while Celestica shows promise, other AI stocks may offer higher returns with limited downside risk, indicating a competitive landscape in AI investments [2]

Core Insights - DXP Enterprises, Inc. has completed the acquisition of APSCO, LLC, enhancing its water and wastewater platform [1][3] - APSCO, founded in 1986, is a leading manufacturer's representative in the water and wastewater industry, servicing multiple states [2][4] - The acquisition was funded with cash from DXP's balance sheet, indicating a strategic investment in expanding its market presence [2][5] Financial Summary - APSCO reported sales of approximately $12.9 million and adjusted EBITDA of $1.5 million for the twelve months ending July 31, 2025 [4] - Adjusted EBITDA is defined as income before tax, plus interest, depreciation, amortization, and non-recurring items, minus go-forward selling costs [4] Strategic Implications - The acquisition is expected to enhance DXP's product and aftermarket service capabilities, contributing to the growth of its DXP Water platform [3][5] - DXP aims to continue its acquisition strategy in the water and wastewater sector, with plans for further acquisitions into 2026 [5]

Group 1 - Cardinal Health, Inc. (NYSE:CAH) is recognized as one of the 11 cheap quarterly dividend stocks to buy currently [1] - The company is a significant distributor of branded and generic drugs, medical supplies, and laboratory products, serving over 90% of hospitals in the US and operating in more than 30 countries [2] - Cardinal Health has a strong dividend history, having raised its payout for 39 consecutive years, with a payout ratio of about 25% of this year's expected earnings, indicating potential for further increases [3] Group 2 - The current quarterly dividend offered by Cardinal Health is $0.5107 per share, resulting in a dividend yield of 1.32% as of September 23 [4] - Analysts project an earnings growth of nearly 11% annually over the next three to five years, which could support continued dividend expansion [3]